TriangleNCT00322491 · OUTCOME
Median Cumulative Number of CD34+ Cells Collected During Apheresis
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEDIAN
- Unit
- CD34+ cells (*10^6 / kg)
- Interval / dispersion
- Full Range
- Time frame
- Days 5-8
What was measured
Median cumulative total number of CD34+ cells collected during apheresis.
Analysis population: Participants who received at least one dose of plerixafor
Groups in this outcome
Non-Hodgkin's Lymphoma (NHL)
Participants with NHL were mobilized with granulocyte colony-stimulating factor (G-CSF) 10 µg/kg/day for 4 days. Plerixafor 240 µg/kg was given the evening of day 4 and G-CSF given the next morning followed by apheresis. Evening doses of plerixafor and morning doses of G-CSF followed by apheresis continued for up to a maximum of 5 aphereses or until ≥ 5\*10\^6 CD34+ cells/kg were collected.
Multiple Myeloma (MM)
Participants with MM were mobilized with granulocyte colony-stimulating factor (G-CSF) 10 µg/kg/day for 4 days. Plerixafor 240 µg/kg was given the evening of day 4 and G-CSF given the next morning followed by apheresis. Evening doses of plerixafor and morning doses of G-CSF followed by apheresis continued for up to a maximum of 5 aphereses or until ≥ 5\*10\^6 CD34+ cells/kg were collected.
All Participants
Not reported
| Group | Source count |
|---|---|
| Non-Hodgkin's Lymphoma (NHL) | 23 |
| Multiple Myeloma (MM) | 26 |
| All Participants | 49 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Non-Hodgkin's Lymphoma (NHL) | 5.2 | Not reported | 1.5 | 18.9 | Not reported |
| Multiple Myeloma (MM) | 11.1 | Not reported | 4.4 | 22.5 | Not reported |
| All Participants | 5.9 | Not reported | 1.5 | 22.5 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 1.5
- upper Limit
- 18.9
- value
- 5.2
- group Id
- OG001
- lower Limit
- 4.4
- upper Limit
- 22.5
- value
- 11.1
- group Id
- OG002
- lower Limit
- 1.5
- upper Limit
- 22.5
- value
- 5.9
- denoms
- counts
- group Id
- OG000
- value
- 23
- group Id
- OG001
- value
- 26
- group Id
- OG002
- value
- 49
- units
- Participants
- description
- Median cumulative total number of CD34+ cells collected during apheresis.
- dispersion Type
- Full Range
- groups
- description
- Participants with NHL were mobilized with granulocyte colony-stimulating factor (G-CSF) 10 µg/kg/day for 4 days. Plerixafor 240 µg/kg was given the evening of day 4 and G-CSF given the next morning followed by apheresis. Evening doses of plerixafor and morning doses of G-CSF followed by apheresis continued for up to a maximum of 5 aphereses or until ≥ 5\*10\^6 CD34+ cells/kg were collected.
- id
- OG000
- title
- Non-Hodgkin's Lymphoma (NHL)
- description
- Participants with MM were mobilized with granulocyte colony-stimulating factor (G-CSF) 10 µg/kg/day for 4 days. Plerixafor 240 µg/kg was given the evening of day 4 and G-CSF given the next morning followed by apheresis. Evening doses of plerixafor and morning doses of G-CSF followed by apheresis continued for up to a maximum of 5 aphereses or until ≥ 5\*10\^6 CD34+ cells/kg were collected.
- id
- OG001
- title
- Multiple Myeloma (MM)
- id
- OG002
- title
- All Participants
- param Type
- MEDIAN
- population Description
- Participants who received at least one dose of plerixafor
- reporting Status
- POSTED
- time Frame
- Days 5-8
- title
- Median Cumulative Number of CD34+ Cells Collected During Apheresis
- type
- OTHER_PRE_SPECIFIED
- unit Of Measure
- CD34+ cells (*10^6 / kg)
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice